药物不良反应信号 矿山 amiodarone 和 dronedarone 的比较:基于 FAERS 的药监测研究
1Department of Cardiology, Intervention Cardiology Center, Wuhan No. 1 Hospital, Wuhan, China.
Frontiers in pharmacology
|November 6, 2024
概括
这项研究使用FAERS数据分析了amiodarone和dronedarone的药物不良反应 (ADR). 德罗内达龙比阿米奥达龙具有更高的心脏毒性,但甲状腺毒性较低,这凸显了需要仔细监测的必要性.
科学领域:
- 药物监督 药物监督 药物监督
- 在药理学中数据挖掘.
- 临床药理学 临床药理学
背景情况:
- 阿米奥达龙和德龙达龙是III类抗心律失常药物,用于治疗心律失常.
- 与这些药物相关的不良药物反应 (ADR) 需要进一步调查以确保安全的临床应用.
研究的目的:
- 通过数据挖掘,增强对阿米奥达龙和无人机的不良反应的理解.
- 为这些抗心律失常药物的安全有效临床使用提供参考.
主要方法:
- 分析2011年第三季度至2023年第三季度美国食品和药物管理局不良事件报告系统 (FAERS) 数据.
- 应用不成比例分析算法 (ROR,PRR,BCPNN,EBGM) 来检测ADR信号.
- 通过Z测试和费舍尔精确测试,根据器官毒性对阿米奥达龙和德龙达龙的ADR概况进行比较.
主要成果:
- 艾米奥达龙的显著不良反应包括药物相互作用,甲状腺功能过高和呼吸障碍;对于德龙达龙,心房动,呼吸障碍和血中肌水平升高.
- 对阿米奥达龙 (例如,心电图T波替代物,甲状腺炎) 和德龙达龙 (例如,心脏切除,消) 发现的意外ADR信号.
- 与amiodarone相比,dronedarone表现出更高的心脏毒性,但甲状腺毒性较低.
结论:
- 调查结果强调了警监测amiodarone和dronedarone风险的重要性.
- 识别新的不良反应和独特的不良反应概况有助于临床医生确保安全使用这些抗失常药物.
相关概念视频
Pharmacovigilance
776
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
776
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
914
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
914
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
709
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
709
Dose-Response Relationship: Selectivity and Specificity
6.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.5K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


